Posts in category: Uncategorized

A new report released today by the Asia Pacific Oncology Alliance (APOA), a network of stakeholders from across the cancer continuum who are committed to improving cancer care in Asia Pacific, highlights the importance of the patient voice in improving cancer experiences and outcomes across the region.

A 36-year-old Brazilian man made headlines around the world in 2020 for being the first person to be putatively cured of human immunodeficiency virus (HIV) using an easily accessible and well-tolerated drug cocktail.

As the use of wearable technology grows, smart watches are marketed across the globe to consumers as a way to monitor health.

New research delves into a traditionally overlooked category of chronic hepatitis B (CHB) patients. While those who are HBeAg-negative with normal ALT levels have been considered low-risk and often excluded from immediate treatment, this study challenges that notion by demonstrating the considerable benefits of ongoing antiviral therapy.

The authors of a new study are warning people with type 1 diabetes to use fitness video games with caution.

By LUCY PHIRI

FORMER Lusaka Province Minister, Bowman Lusambo’s attempting to interfere with witness case failed to take off yesterday at the Lusaka Magistrate Court.

To overcome problematic opioid use, traditional forms of opioid substitution therapy, such as methadone and oral buprenorphine, have become valuable tools. Research shows that patients receiving substitution therapy are more likely to stay in treatment and stop using heroin than patients receiving treatments that do not involve substitutes—such as counseling or group therapy.

Titanium hip implants do not last forever—they gradually loosen, sooner or later losing their hold on the bone as it recedes over time. Researchers at the Fraunhofer Institute for Applied Polymer Research IAP have been working alongside the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB and the Fraunhofer U.S. Center for Manufacturing Innovation CMI to develop a tissue adhesive that can help avoid early replacement of prostheses in the future.

Just over 40 years ago, the first case of acquired immunodeficiency syndrome—more commonly known as AIDS—was reported, setting into motion a worldwide panic about the unknown, devastating disease. At the time, AIDS was universally considered to be a death sentence.

An initiative at a Texas hospital contributed to reductions in chest tube duration, hospital length of stay and readmissions for patients with lung cancer who had a pulmonary lobectomy, according to new research published in Critical Care Nurse.